Signals from dying cells may drive altered skin cell growth through prostaglandin E2

Altered or mutant cell

An altered cell differs from the reference cell state; a mutant cell specifically carries a genetic change. These labels do not by themselves establish that a cell is dangerous.

Clone

A family of cells descended from one original cell. Clone expansion means that this family increases in size or occupies more tissue.

Lesion

A localized patch of abnormal tissue. Its visible disappearance measures clearance of that patch, not necessarily elimination of every altered cell.

RL-3

The pipeline's label for the proposed skin treatment. The supplied material provides no expansion of the label or description of its components or method.

Cell competition and competitive release

Cell competition describes how neighboring cell populations influence which cells persist or expand. Competitive release is the proposed reduction of that restraint after competitors are removed; its occurrence after the treatment in this question remains unestablished.

Deep surviving reserves

The pipeline's proposed cells deeper in the skin that remain after surface lesions clear. Their location, identity and survival after treatment are not established by the supplied sources.

Epidermis

The outer layer of skin. The epidermis between hair follicles is the part of that layer outside the structures from which hairs grow.

Stem cell

A cell capable of maintaining its population while supplying cells to a tissue. Its persistence and descendants' expansion are the outcomes discussed in S2 and S4.

Deoxyribonucleic acid

The molecule that carries genetic information. S2 concerns cells with damage that breaks both strands of this molecule.

p53 mutation

A genetic change affecting p53, a protein involved in controlling cell responses to damage. The supplied findings concern particular p53-mutant cell populations and do not establish that every such mutation has the same consequences.

Logistic growth curve

A growth pattern in which expansion slows as the growing population approaches a limit. S6 uses this pattern to describe the approximate growth of the studied mutant clones.

Crowding feedback and tissue homeostasis

Crowding feedback means that local cell density changes how cells behave. Tissue homeostasis means maintaining stable tissue organization through ongoing cell activity; S6 links this stability to responses to crowding.

Simulation

A model that calculates how a system behaves under specified rules. S6's modeled results do not themselves establish what repeated treatment does in human skin.

Selective growth advantage

A relative advantage that allows one cell population to expand more successfully than others in a particular setting. It depends on context and does not itself measure damage to the organism.

Rheumatoid arthritis synovium

Joint-lining tissue affected by rheumatoid arthritis, an inflammatory disease. This is the tissue setting of S7, rather than skin.

RL-3 removes active lesions, but release from cellular competition and deep surviving reserves limit what visible clearance establishes about long-term risk.

RL-3 is the treatment label supplied by the pipeline, and lesions are patches of abnormal skin that it is said to remove. The assumption is that cells remaining nearby or deeper in the skin can behave differently after removal changes their surroundings. If true, disappearance of visible patches would leave unanswered whether dangerous cell families are still expanding.

S4 supports the narrower claim that spatial surroundings and cell competition influence the fate of altered skin stem cells. S6 reports a role for responses to crowding in maintaining stable tissue organization in simulations. Neither establishes that RL-3 clears lesions, that deep reserves survive it, or that repeated clearance releases dangerous survivors from competition. The supplied sources therefore support part of the ecological rationale, while leaving the treatment-specific assertions unestablished.S4S6

The same question asked without the part nothing read establishes:

• Does repeated removal of altered skin cells accelerate surviving clones despite visible lesion clearance, and does preserving competing neighbors prevent that acceleration?
• How does preserving neighboring cells change surviving clone growth after repeated removal of altered skin cells?

• Removal accelerates survivors; preserved neighbors prevent it Under the proposed mechanism, removal reduces competition and surviving dangerous clones expand faster despite visible clearance. If preserving neighbors blocks that acceleration, the cellular surroundings would determine whether clearance carries this hidden cost.
• Removal accelerates survivors; preserved neighbors do not prevent it Dangerous survivors would expand faster after removal even when neighboring competitors remain. Visible clearance and neighbor preservation would then both be insufficient to establish control of the surviving clones.
• Removal does not accelerate dangerous survivors Repeated removal would not produce the particular competitive-release effect posed by the question. That outcome alone would still not establish ten-year control or detection before lasting damage, because those are separate outcomes.

Visible lesion clearance and the subsequent growth of surviving cells are different outcomes. The proposed concern is that removing cells reduces competition, which could give dangerous survivors more room to expand; the supplied sources do not establish this sequence after repeated treatment. If that sequence occurs, clearer-looking skin could conceal worsening underlying risk. If preserved neighbors prevent the acceleration, their retention would change the consequences of removal, but their mere presence cannot be assumed to provide protection.